We studied the ultrastructure and the synaptic arrangement of glutamate-immunoreactive terminals in rats, in the superficial laminae of the spinal cord, the brainstem cuneate nudeus, and the thalamic ventropostemlateral nudeus, where a role for glutamate as neurotransmitter has been suggested by biochemical, physiological and pharmacological approaches. The antiserum employed was raised against glutamate conjugated to keyhole limpet hemocyanin with glutaraldehyde, and was used for pre-embedding staining with an avidin-biotin-peroxidase method and for post-embedding staining with an immunogold procedure. Both methods yielded similar results, consisting of labeling of selected terminals in all the areas examined. Double immunogold labeling on the same thin section using antisera
Introduction
Over the past 30 years, increasing evidence obtained with different approaches has indicated that two widely distributed amino acids, glutamate and aspartate, not only are involved in a number of metabolic reactions but also meet many of the criteria required of putative excitatory transmitters (11,18,30,39,49). In particular, neurochemical, physiological, and pharmacological studies have suggested that these excitatory amino acids are involved in the transmission and processing of somatosensory information from the peripheral to the central nervous system (for review see 42,43). The biochemical and pharmacological methods employed to detect glutamate and aspartate, however, had inherently low topographical resolution, and the autoradiographic techniques, which were based on the uptake of radiolabeled glutamate, aspartate, or their analogues (12), could not distinguish between glutamate-and aspartatecontaining neurons, as both types of cells appear to use the same ' Supported by grants USPHS 12440, CNR 89.03046.04, and MURST.
Correspondence to: Dr. Silvia De Biasi. Sezione Istologia, Dip Fisiologia e Biochimica, via Celoria 26, 1-20133 Milano, Italy. Presented in p u t at the symposium on EXCITATORY AMINO ACID NEUROTRANSMITTERS AND THEIR RECEPTORS. August 9,1990, as part of the program at the third joint meeting of the Japan Society of Histochemistry and Cytochemistry and The Histochemical Society, held in Seattle, Washington, August 8-11. against y-amino-butyric acid (GABA) or substance P (SP), in combination with the anti-glutamate serum, showed that staining for glutamate and GABA was present in different terminals in all the regions examined; glutamate and SP were co-localized in a few terminals only in the superficial laminae of the spinal cord. By performing immunogold staining in combination with anterograde tracing, glutamate immunoreactivity could be localized in identified primary afferents to the dorsal spinal cord and cuneate nudeus, and in lemniscal afferents to the thalamus. (]Hisrochem Cyro- c h~n 38: [1745] [1746] [1747] [1748] [1749] [1750] [1751] [1752] [1753] [1754] 1990) high-affinity uptake mechanism (3). The anatomic identification of specific neurons using excitatory amino acids therefore remained difficult until the development in recent years of antibodies against glutamate and aspartate. After the pioneering work of Storm-Mathisen and collaborators (46), several polyclonal antisera and monoclonal antibodies (2,7,8,23-26,34,35,44,47) against glutamate and aspartate were produced and were used to describe the morphology and distribution of excitatory amino acid-containing neurons in different areas of the central nervous system of several animal species.
In the present work, the morphology and synaptic arrangement of terminals labeled with an anti-glutamate serum raised in rabbits against glutamate conjugated to keyhole limpet hemocyanin (23) were studied in regions of the rat nervous system involved in the transmission and processing of somatosensory messages, such as the superficial laminae of the spinal cord, the brainstem cuneate nucleus, and the ventroposterolateral (VPL) nucleus of the thalamus. To further characterize the neuronal circuits in which the glutamate-labeled terminals are involved, double immunolabeling experiments were performed using the anti-glutamate serum in combination with an anti-GABA or an anti-SP serum. GABA is a major inhibitory transmitter in the regions under investigation (42), and SP is an extensively studied neuropeptide which has been suggested as a mediator in the somatosensory system, mainly in-
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DE BIASI, RUSTIONI volved in the transmission of noxious stimuli (42, 43) . Both GABA and SP have been previously visualized immunocytochemically in the dorsal spinal cord (27.38) . cuneate nucleus (9,41) and thalamus (5,13). Finally, to associate the glutamate-labeled terminals with specific neuronal pathways, the origin of some of the glutamateimmunopositive terminals was investigated by combining the immunostaining with the use of an anterograde tracer.
Preliminary results have already been published in abstract form (14, 16, 45) .
Materials and Methods

Tissue Preparation
Adult albino rats, weighing 200-250 g, were anesthetized with chloral hydrate (350 mglkg intraperitoneally) and perfused through the ascending aorta with a d i n e r i w and then with 500 ml ofone ofthe following fmtive mixtures. freshly prepared in 0.1 M phosphate buffer (PB) at pH 7.4: hyde and 0.54% glutualdehgd~; (d) 2.5% glutualdehydc and 0.5% &or-
Immunocytocbemiztry
Rimvg Antbaa. The anti-glupmnte serum was niscd in rabbits against g l u m a t e conjugated to keyhole limpet hemocyanin with glutaraldehyde. Its complete characterization and specificity have been previously described in detail (23). Rabbit anti-GABA serum was purchased from Incstar (Stillwater, MN). The anti-SP serum was n i x d in rabbits against SP conjugated to ovalbumin by glutaraldehyde and its specificity vsessed by both radioimmunoassay and immunocytochemistry (Abdullah and Peuusz, personal communication). No crossreactivity with neurokinin A (6) or other neuropeptides known to be present in dorsal root ganglion neurons, was obsemd.
for 30 min in normal goat serum (NGS; 10% in PBS), and then incubated overnight at 4'C in the anti-glutamate serum (1:1O,O00-1:2O,O00 in PBS with 1% NGS). On the following day. sections were rinsed in PBS and incubated for 1 hr at room temperature in biotinylated goat anti-rabbit IgG (Vector Laboratories; Burlingame, CA; 1:200 in PBS), rinsed in PBS, and tnnsfemd to a solution containing the avidin-biotin-HRF'complac (ABC. Vector) for 1 hr at room temperature. After rinses in PBS, sections wcre incubated in 3,3'-diaminobenzidine (DAB, Sigma; 0.075% in Tris buffer 0.05 M, pH 7.6) with 0.001% H202 for 10 min. Rcprcxntativc sections from each brain region were osmicated in 1% os04 for 1 hr and waferembedded in Epon. Ultra-thin sections were examined under the electron microscope with or without uranyl acetate and lead citrate countermining.
Post-embedding Immunopld Stlining. Ultra-thin sections collected on formw-coated nickel grids were tmted for 30 min with a saturated aqueous solution of sodium metaperiodate (Sigma). After rinses in distilled water and a 30-min incubation in 3% NGS diluted in 0.05 M Trisbuffered d i n e , pH 7.4, with 0.1% bovine serum albumin and 0.5% sodium azide (TBS-BSA), grids were immersed for 1 hr at room temperature in drops of anti-glutamate serum (1:1O,OOO in TBS-BSA), thoroughly rinsed RHmbcddLy Immun-g.
Frrc-fl-ting &OILS b e d in TBS-BSA. and incubated for 1 hr at room temperature in a solution of colloidal gold particles coated with goat anti-rabbit immunoglobulin G (GAR, 10 and 20 nm; BioCell Rc#uch Laboratories, Cardiff, UK) diluted 1:20-1:40 in TBS-BSA, pH 8.2. For double immunolabeling the sequentid method of Wang and Larsson (48) was u x d because it allows the simultaneous visualization of different antigens on the same thin section. using antibodies n i x d in the same species. After the f m cydc of immunostaining (fm primary antiscrum, usually anti-GABA at 1:2000 or anti-SP at 1:1O.O00, r d e d by GAR lo), free anti-immunoglobulin binding sites were denatured by hot p d o rmaldehyde vapors. The grids were then incubated in the second primary antiscrum (anti-glutamate at 1:10,000) and in GAR 20 nm. After several r i w s in TBS and in distilled water. grids were conuvted with m y 1 acetate and lead citrate.
Controls. Specificity of the immunostaining was evaluated by absorption experiments in which the primary antiscrum diluted for tissue mctions was exposed to an excess of the appropriate antigen. Method specificity was controlled by the application of rabbit non-immune serum as well as by the processing of a series of immunomctions in which wious stages were omitted from the regular suining sequence. For double immunartPiaiag experiments, the efficacy of thermal denaturation was tested by treating the sections with hot paraformaldehyde vapors after incubation in the primary antiserum.
Tracer InjectionJ
Under anesthesia, rats were mounted on a stereotaxic fnme and 0.2-0.5 p1 of a 2% solution ofwheat germ agglutinin-conjugated horseradish peroxidase (WGA-HRP; Sigma) were injected into cervical dorsal root ganglia C4-C7 to label primary lfferent terminals in the spinal cord and cuneate nucleus or into the dorsal column nudei to label lemniscal &rents in the VPL nucleus in the thalamus. Twenty-four to 48 hr after surgery, rats were perfused uulscardially with 2.5% glutvlldehyde and 0.5% paraformaldehyde. Vibratome sections (50 pm thick) of spinal cord, caudal medulla, and thalamus were processed for the histochemical localization ofthe transported HRP, using a duomogen eitherpum-phenylenediamine pyrocatechol (PPD-PC; Flub. Chemic A G Buchs, Switzerland), which gives rise to an elmron-dew. membrane-bound reaction product (13, 14, 21) or 3 3 , 5,s'tetramethylbenzidine (TMB, Sigma), which gives rise to an electron-dew crystalline reaction product (22, 33) . After light microscopic inspection, selected sections were osmicated and wafer-embedded in Epon. Ultra-thin sections collected on nickel grids were processed for immunogold staining with the anti-glutamate serum as described abovc.
ReSUltS
General Considerations Regarding Immunostaining
In each of the regions examined, the same pattern of labeling was observed with the pre-and post-embedding immunolabeling methods employed, i t . , the same morphological types of terminals were either labeled or unlabeled, and no immunostaining was 
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DE BIASI, RUSTIONI tained using fixatives c and d were comparable, whereas no labeling was present with the use of fixatives a and b. Gold particles representing glutamate immunostaining were seen over mitochondria and clear synaptic vesicles and scattered in the cytoplasm in labeled profiles (Figures le, 2a, and 2c) .
Most of the data reported were obtained with immunogold staining, as this method enabled us (a) to avoid problems related to the penetration of the immunoreagents and (b) to obtain a more detailed description of the labeled terminals and of their synaptic relationships, owing to the better preservation of the tissue and the possibility to combine immunostaining with tracer injections and to perform multiple immunostainings.
The term glutamate-immunoreactive (Glu-ir) will be used in the following discussion to indicate structures labeled with the antiglutamate serum used.
Labeling in Spinal Cord and Cuneate Nucleus
In the superficial laminae (lamina I and 11) of the spinal cord, labeling for glutamate was found in two main types of synaptic terminals, morphologically identifiable as dome-shaped (Figures la-lc) and scalloped ( Figures Id, le, and 2a ). Both types contained many round, clear synaptic vesicles and established Gray Type I asymmetric synapses with labeled or unlabeled postsynaptic elements. Variable numbers of large granular vesicles (LGV) were also present in some of the Glu-ir terminals, but they were not tagged by gold particles &er incubation in the anti-glutamate serum (Fig  ure 3b ). Dome-shaped terminals (Figures la-lc) were small-to medium-sized, had a dark (Figure la) or a light ( Figure Ib) axoplasm, and synapsed on a single small-caliber dendrite which was sometimes also contacted, in the plane of the section, by other terminals ( Figure Ib) . Scalloped terminals (Figures Id, le, and 2a) were characterized by an indented contour and by their large size. They typically contacted many postsynaptic profiles, mostly represented by small dendrites (Figures Id, le, and 21 ) and were involved in axo-axonic contacts with unlabeled profiles (Figure 2a ). These morphological characteristics corresponded to the central glomerular terminals observed in the dorsal horn of several mammalian species (28). In lamina 11, scalloped terminals belonging to the two main morphological types previously described in rat (37) were found to be Glu-ir. Type I terminals were characterized by a sinuous profile and by dark axoplasm containing clear vesicles, heterogeneous in size, and a few LGV and mitochondria ( Figures Id and  IC) . Type I1 terminals had light cytoplasm with loosely arranged clear vesicles, uniformly small, and many mitochondria (Figure 2a ). These terminals lacked LGV but some contained small bundles of neurofilaments.
In the cuneate nucleus, labeling for glutamate was found in small and large terminals having light axoplasm and containing round, clear vesicles homogeneous in size (Figures 2b and 2c) and only occasional LGV. Small terminals were dome-shaped and made an isolated synapse on a single dendrite (Figure 2c ). Large terminals had an irregular profile, contacted dendrites of variable Caliber, and received axo-axonic synapses from unlabeled terminals (Fig  ure 2b) .
In every thin section of dorsal horn and cuneate nucleus observed, not all the terminals with a dome shape or with a scalloped profile were Glu-ir. Moreover, terminals with flat vesicles and establishing Gray Type I1 symmetric synaptic contacts were not labeled by the anti-glutamate serum (Figures Ib, Za, and 3b) .
When double immunostaining with the anti-glutamate ahd the anti-GABA sera was performed on sections of spinal cord ( Figure  3a ) and cuneate nucleus, immunoreactivity for the two antigens was found in separate terminals in the same thin section. Some of the GABA-labeled boutons synapsed on the Glu-ir scalloped terminals (Figure 3a) .
Double immunostaining with the anti-Glu and the anti-SP sera showed that in every thin section the two antigens were segregated in different cytoplasmic compartments, because labeling for the neuropeptide was found only over the LGV, both in terminals and in cell bodies. In the superficial laminae of the spinal cord, some of the dome-shaped and scalloped Glu-ir terminals contained LGV labeled by the anti-SP serum (Figure 3b ). In the cuneate nucleus, SP labeling was present only in small dome-shaped terminals containing many round, clear vesicles and a few scattered LGV, and making asymmetric synapse on a single dendrite. Co-existence of glutamate and SP immunoreactivity in the same terminal was not observed in this nucleus.
Injection of WGA-HRP in dorsal root ganglia resulted in anterograde labeling of many large terminals in spinal dorsal horn and cuneate nucleus, therefore directly identlfying them as primary afferents. Immunostaining with the anti-glutamate serum of thin sections from these samples showed that most of the identified (HRP-labeled) terminals were Glu-ir (Figures 3c and 3d ).
Labeling in VPL
In the VPL thalamic nucleus, glutamate labeling was found in two types of terminals, mainly characterized by their &rent size. Some of the Glu-ir terminals were small, dome-shaped, and contained round, clear vesicles, densely packed, and very few mitochondria (Figure 4a ). They established a single asymmetric synapse on smallcaliber dendrites which could receive, on the plane of the section, synaptic contacts from other labeled or unlabeled terminals (Figure 4a) .
Other Glu-ir terminals were large and contained many round, clear vesicles and mitochondria (Figures 4b-4d ). They synapsed on shafts of large dendrites and their spines, and more rarely on cell bodies. They also established non-synaptic adhesions (puncta adherentia) with the shaft of large dendrites and were not involved in axo-axonic synapses or complex synaptic arrangements with other terminals. Both types of Glu-ir terminals occasionally contained a few LGV (Figures 4c and 4d) . In every thin section examined, not all the small or large terminals were Glu-ir (Figure 4a) ; terminals containing flat or pleomorphic vesicles and establishing symmetric synaptic contacts were unlabeled (Figure 4d ).
Double labeling experiments confirmed that glutamate and GABA immunoreactivities were present in different synaptic profiles ( Figure 4c ) and showed that no co-localization of glutamate and SP was present, even in Glu-ir terminals containing LGV.
After injection of WGA-HRP in the dorsal column nuclei, anterograde labeling was found only in large terminals, which could therefore be identified as lemniscal afferents. Most of these HRPlabeled terminals were Glu-ir (Figure 4d ). 
--
Discussion
In the course of the present study, a polyclonal antiserum was used in three regions of the rat somatosensory system to visualize Glu-ir terminals and to attempt to relate them to specific neuronal pathways. The anti-glutamate serum used has been extensively characterized and was found to be selective for glutamate out of a number of other amino acids and dipeptides, by means of absorption tests on various parts of the nervous system and by immunoblots (4.10.23). Specificity of the antiserum for the respective hapten, rather than for the cross-linking agent (glutaraldehyde) or the carrier protein (hemocyanin), was indicated by the occurrence of immunological recognition in tissue fixed with paraformaldehyde and by the blocking of the stain in the presence of glutamate conjugated to hemocyanin by paraformaldehyde (4) or unconjugated (51). The absence of post-embedding staining in tissue fixed with carbodiimide or with paraformaldehyde alone was probably due to the inability of these fixatives to retain glutamate in the tissue during the dehydration and embedding steps.
Because excitatory amino acids are essential components in cellular metabolism, it is d8icult to demonstrate that glutamate pools stained by the antiserum used in this study are exclusively transmitter-related. The issue of recognition by the antiserum of a neurotransmitter vs a metabolic pool of glutamate has been discussed in several publications. In brief, that the immunostaining obtained may be related to the released transmitter is supported by: (a) the lack of correlation between immunostaining for glutamate observed in various regions of the nervous system and the pattern of labeling observed with metabolic markers, e.g., cytochrome oxidase (4,lO); (b) the likelihood that the metabolic pool of glutamate, synthesized at a lower rate than the neurotransmitter pool, may be depleted during the fixation (47); (c) the lack of staining of neurons known to be GABAergic and thus containing glutamate as a precursor, e.g., in somatosensory cortex (10) and in cuneate and VPL nuclei (40); (d) the selective staining with the glutamate antiserum of synaptic terminals, where transmitter-related glutamate is expected to be present in particularly high concentrations.
Selectivity of the immunolabeling was demonstrated by the fmding that glutamate staining is enriched only in certain categories of nerve terminals in the three regions examined, and that not all the terminals with a similar morphology are immunoreactive. Immunogold staining allowed us to exclude the possibility that the unlabeled profiles observed in pre-embedding immunoreacted tissue might result from lack of penetration of the reagents, especially as no permeabilization treatment was used. In Glu-ir synaptic terminals, gold particles were distributed ovcr mitochondria and over round, clear synaptic micles. leaving LGV untaggcd. This subcellular pattern of immunolabeling has been observed with other anti-glutamate sera (24.47) and is in agreement with biochemical data on isolated synaptosomes showing the presence of glutamate biosynthetic enzymes in mitochondria (36) and accumulation of glutamate in vesicles (29).
The selectivity of glutamate immunostaining was further confirmed in experiments in which the same thin section was sequentially incubated in antisera against two different antigens. Glutamate and GABA immunoreactivities were found in distinct profiies; glutamate and SP immunoreactivities were always segregated in different cytoplasmic compartments, even when present in the same synaptic terminal, the neuropeptide being confined to the LGV.
Moreover, when properly cut in the plane of the section, the synapse established by the Glu-ir terminals was always asymmetric (Gray Type I), with a marked thickening of the postsynaptic membrane.
Because this type of synapse is considered excitatory, the result is in line with the known excitatory action exerted by glutamate. Finally, the pattern of labeling obtained agrees with other reports showing similar types of Glu-ir terminals in the dorsal horn (31.50) and in the geniculate nucleus of the thalamus (32) with the use of the same or other antisera against glutamate.
The visualization of Glu-ir terminals in the superficial laminae of the spinal dorsal horn, in the brainstem cuneate nucleus, and in the WL nucleus of the thalamus provided anatomic support for the growing body of biochemical, pharmacological, and physiological evidence (42,43) suggesting that glutamate is involved in the transmission and processing of somatosensory information. Some of the Glu-ir terminals in the dorsal horn and in the cuneate nucleus were directly demonstrated to be primary afferents, i.e., to originate from dorsal root ganglion neurons, by the use of an anterograde tracer. This result is in line with previous immunocytochemical studies showing that many dorsal root ganglion cells (4) and dorsal root axons (51) are Glu-ir, and with biochemical, pharmacological, and physiological data (42,43). The morphological characterization of the Glu-ir terminals indicated that several types of sensory modalities may use glutamate as neurotransmitter. The superficial laminae of the dorsal horn receive primary afferent terminals from small myelinated and unmyelinated fibers, mediating inputs from mechano-, thermo-, and polymodal nocireceptors, whereas the greatest majority of primary afferent input to the cuneate nucleus is from large myelinated fibers mediating inputs from innocuous mechanoreceptors (28,42,43). In both regions, however, Glu-ir primary afferents were found to receive synaptic contacts from GABA-labeled terminals, in line with the detection of GABA receptors on smd-caliber primary &rent fibers (17) and with the demonstration of primary afferent depolarization associated with pre-synaptic inhibition (1).
In WL, some of the large Glu-ir terminals were identified as lemniscal afferents, in line with the light microscopic demonstration of Glu-ir neurons in the dorsal column nuclei (40) and with pharmacological and physiological evidence (42). These terminals, believed to convey discriminative touch, vibratory sensibility, and position sense, were not contacted directly by GABA-labeled terminals. Small dome-shaped terminals found to be Glu-ir in the three regions examined may originate from the somatosensory cortex. Morphologically similar terminals were demonstrated to originate from this region by means of degeneration and tracing methods (42). Moreover, studies combining h u n o s t a i n i n g for glutamate and retrograde labeling have shown that some of the Glu-ir pyramidal cells in the somatosensory cortex do project to spinal cord and thalamus (19,20) , thus supporting the existence of a cortical control of somatic inputs mediated by glutamate, previously inferred from biochemical and pharmacological data (42). 
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